Complications of Exchange Transfusion in Neonates
NCT03195049 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2017-06-22
Summary
Exchange transfusion is effective and considered to be safe procedure ; however, it is not without risks. Complications have been reported and mortality rates vary from 0.5 to 3.3%. therefore ,the current recommendation for performing exchange transfusion are based on balance between the risks of encephalopathy and complications related to the procedure .
Conditions
- Kernicterus
Interventions
- DIAGNOSTIC_TEST
-
blood group,complete blood count
measure levels of total and direct bilirubin before, during and after the procedure of exchange transfusion
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Hanaa Ab Mohamed, Professor · Assiut University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Day
- Max Age
- 4 Weeks
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-15
- Primary Completion
- 2019-04-15
- Completion
- 2019-09-15
More Related Trials
-
Erythropoietin in Management of Neonatal Hypoxic Ischemic Encephalopathy
NCT03163589 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility Disease
NCT03130517 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Correlation Between Red Cell Transfusion and Complications of Prematurity
NCT07123948 ·Status: NOT_YET_RECRUITING
-
Erythropoietin in HIE Neonate
NCT06590155 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants
NCT01203514 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy
NCT02551003 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anemia
NCT06984445 ·Status: RECRUITING
-
Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy
NCT02455830 ·Status: UNKNOWN
-
Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy
NCT02256618 ·Status: COMPLETED ·Phase: PHASE1
-
Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department
NCT02446951 ·Status: COMPLETED
-
Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration
NCT04584983 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Moderate Hypothermia in Neonatal Hypoxic Ischemic Encephalopathy
NCT02826941 ·Status: COMPLETED ·Phase: PHASE2
-
High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study
NCT00589953 ·Status: TERMINATED ·Phase: PHASE2
-
Withholding Feeds During Red Blood Cell Transfusion and TRAGI
NCT02132819 ·Status: UNKNOWN ·Phase: PHASE4
-
Fluid in Neonatal Hyperbilirubinemia
NCT03684499 ·Status: UNKNOWN ·Phase: NA
-
Neonatal Hypoxic Ischemic Encephalopathy : Safety and Feasibility Study of a Curative Treatment With Autologous Cord Blood Stem Cells
NCT02881970 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Inflammation and Cerebral Oxygenation in Preterm Newborns Following Fetal Red Blood Cell Transfusion Compared to Adult Red Blood Cell Transfusion
NCT06851390 ·Status: COMPLETED
-
Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease
NCT00288600 ·Status: COMPLETED ·Phase: PHASE4
-
Red Blood Cell (RBC) Survival Following Transfusion in Infants
NCT00731588 ·Status: COMPLETED ·Phase: PHASE2
-
Serum Erythropoietin Level in Perinatal Asphyxia
NCT05018364 ·Status: COMPLETED
-
Fetoscopic Selective Laser Photocoagulation in Twin-Twin Transfusion Syndrome
NCT00345852 ·Status: UNKNOWN ·Phase: NA
-
Cylexin for Reduction of Reperfusion Injury in Infant Heart Surgery
NCT00226369 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
NCT05853601 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Correlation of Risk Factors and Severity of Hypoxic-ischaemic Encephalopathy
NCT02800018 ·Status: COMPLETED
-
Dry Blood Spot Screening Test for Neonatal Cholestasis Patients
NCT03667534 ·Status: UNKNOWN